Differing responses in growth and spontaneous mutation to antibiotic resistance in Bacillus subtilis and Staphylococcus epidermidis cells exposed to simulated microgravity
Anken R (2013) Simulationof microgravity for studies in gravitational biology: principles, devices, and applications. Current Biotechnology 2: 192-200
Campbell E, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, Darst S (2001) Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 104: 901-912
CDC. (2011) (Centers for Disease Control and Prevention) Tuberculosis (TB): Treatment. http://www.cdc.gov/TB/topic/treatment/default.htm
Chubukov V, Sauer U (2014) Environmental dependence of stationary-phase metabolism in Bacillus subtilis and Escherichia coli. Applied Environmental Microbiology 80: 2901-2909
Cohn LD, Becker BJ (2003) How meta-analysis increases statistical power. Psychological Methods 8: 243-253
Cosgrove S, Avdic Ee (2013) Antibiotic Guidelines 2013-2014: Treatment Recommendations for Adult Inpatients, Baltimore, MD: The Johns Hopkins Antimicrobial Stewardship Program.
Crucian B, Stowe RP, Ott CM, Becker JL, Haddon R, McMonigal KA, C.F. S (2009) Risk of Crew Adverse Health Event Due to Altered Immune Response, Vol. HRP-47060, NASA Johnson Space Center, Houston, TX: NASA.
De Boever P, Mergeay M, Ilyin V, Forget-Hanus D, Van der Auwera G, Mahillon J (2007) Conjugation-mediated plasmid exchange between bacteria grown under space flight conditions. Microgravity Science and Technology 19: 138-144.
Fukuda T, Fukuda K, Takahashi A, Ohnishi T, Nakano T, Sato M, Gunge N (2000) Analysis of deletion mutations of the rpsL gene in the yeast Saccharomyces cerevisiae detected after long-term flight on the Russian space station Mir. Mutation Research 470: 125-132
Gleckman R, Blagg N, Joubert DW (1981) Trimethoprim: mechanisms of action, antimicrobial activity, bacterial resistance, pharmacokinetics, adverse reactions, and therapeutic indications. Pharmacotherapy 1: 14-20
Gonzalez C, Hadany L, Ponder RG, Price M, Hastings PJ, Rosenberg SM (2008) Mutability and importance of a hypermutable cell subpopulation that produces stress-induced mutants in Escherichia coli. PLoS Genetics 4: e1000208
Guéguinou N, Huin-Schohn C, Bascove M, Bueb JL, Tschirhart E, Legrand-Frossi C, Frippiat JP (2009) Could spaceflight-associated immune system weakening preclude the expansion of human presence beyond Earth's orbit? Journal of Leukocyte Biology 86: 1027-1038
Horneck G, Klaus DM, Mancinelli RL (2010) Space microbiology. Microbiology and Molecular Biology Reviews 74: 121-156
Ilyin VK (2005) Microbiological status of cosmonauts during orbital spaceflights on Salyut and Mir orbital stations. Acta Astronautica 56: 839-850
ISECG. (2013) (International Space Exploration Coordination Group) The global exploration roadmap., NASA Headquarters, Washington DC.
Jin DJ, Gross CA (1988) Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. Journal of Molecular Biology 202: 45-58.
Kane JF, Wainscot VJ, Hurt MA (1979) Increased levels of dihydrofolate reductase in rifampin-resistant mutants of Bacillus subtilis. Journal of Bacteriology 137: 1028-1030.
Klaus DM, Howard HN (2006) Antibiotic efficacy and microbial virulence during space flight. Trends in Biotechnology 24: 131-136
Lapchine L, Moatti N, Gasset G, Richoilley G, Templier J, Tixador R (1986) Antibiotic activity in space. Drugs under Experimental and Clinical Research 12: 933-938
Maughan H, Callicotte V, Hancock A, Birky CW, Nicholson WL, Masel J (2006) The population genetics of phenotypic deterioration in experimental populations of Bacillus subtilis. Evolution 60: 686-695.
Maughan H, Galeano B, Nicholson WL (2004) Novel rpoB mutations conferring rifampin resistance on Bacillus subtilis: global effects on growth, competence, sporulation, and germination. Journal of Bacteriology 186: 2481-2486.
Navarro Llorens JM, Tormo A, Martínez-García E (2010) Stationary phase in gram-negative bacteria. FEMS Microbiology Reviews 34: 476-495
Nicholson WL, Maughan H (2002) The spectrum of spontaneous rifampin resistance mutations in the rpoB gene of Bacillus subtilis 168 spores differs from that of vegetative cells and resembles that of Mycobacterium tuberculosis. Journal of Bacteriology 184: 4936-4940
Nickerson CA, Ott CM, Wilson JW, Ramamurthy R, LeBlanc CL, Höner zu Bentrup K, Hammond T, Pierson DL (2003) Low-shear modeled microgravity: a global environmental regulatory signal affecting bacterial gene expression, physiology, and pathogenesis. Journal of Microbiological Methods 54: 1-11
Nickerson CA, Ott CM, Wilson JW, Ramamurthy R, Pierson DL (2004) Microbial responses to microgravity and other low-shear environments. Microbiology and Molecular Biology Reviews 68: 345-361
Novikova ND (2004) Review of the knowledge of microbial contamination of the Russian manned spacecraft. Microbial Ecology 47: 127-132
NRC (2014) (National Research Council) Pathways to Exploration: Rationales and Approaches for a U.S. Program of Human Space Exploration. Washington, DC: National Academies Press.
Ott CM, Crabbé A, Wilson JW, Barrila J, Castro SL, Nickerson CA (2012) Microbial stress: spaceflight-induced alterations in microbial virulence and infectious disease risks for the crew. In Stress Challenges and Immunity in Space: From Mechanisms to Monitoring and Preventive Strategies, Chouker A (ed), pp 203-225. Berlin: Springer
Petrosino JF, Galhardo RS, Morales LD, Rosenberg SM (2009) Stress-induced beta-lactam antibiotic resistance mutation and sequences of stationary-phase mutations in the Escherichia coli chromosome. Journal of Bacteriology 191: 5881-5889
Robleto EA, Martin HA, Pedraza-Reyes M (2012) Mfd and transcriptional derepression cause genetic diversity in Bacillus subtilis. Frontiers in Bioscience 4: 1246-1254
Rosenzweig JA, Ahmed S, Eunson J, Chopra AK (2014) Low-shear force associated with modeled microgravity and spaceflight does not similarly impact the virulence of notable bacterial pathogens. Applied Microbiology and Biotechnology doi: 10.1007/s00253-014-6025-8
Sams CF. (2009) The Human in Space: Lesson from ISS. Proceedings of the 6th International Space Life Sciences Working Group. NASA Technical Report, Sonanna, CA USA, p. 45 pp.
Soni A, O'Sullivan L, Quick LN, Ott CM, Nickerson CA, Wilson JW (2014) Conservation of the low-shear modeled microgravity response in Enterobacteriaceae and analysis of the trp genes in this response. Open Microbiology Journal 8: 51-58
Stein GE, Gurwith D, Gurwith M (1988) Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections. Antimicrobial Agents and Chemotherapy 32: 802-806
Tixador R, Gasset G, Eche B, Moatti N, Lapchine L, Woldringh C, Toorop P, Moatti JP, Delmotte F, Tap G (1994) Behavior of bacteria and antibiotics under space conditions. Aviation, Space, and Environmental Medicine 65: 551-556
Tixador R, Richoilley G, Gasset G, Templier J, Bes JC, Moatti N, Lapchine L (1985) Study of minimal inhibitory concentration of antibiotics on bacteria cultivated in vitro in space (Cytos 2 experiment). Aviation, Space, and Environmental Medicine 56: 748-751
van Tongeren SP, Krooneman J, Raangs GC, Welling GW, Harmsen H (2007) Microbial detection and monitoring in advanced life support systems like the International Space Station. Microgravity Sciemce and Technology 19: 45-48.
Vickers AA, Potter NJ, Fishwick CW, Chopra I, O'Neill AJ (2009) Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques. Journal of Antimicrobial Chemotherapy 63: 1112-1117
Wehrli W, Knusel F, Schmid K, Staeheli.M. (1968) Interaction of rifamycin with bacterial RNA polymerase. Proceedings of the National Academy of Sciences of the United States of America 61: 667-673.
Wotring VE (2012) Space Pharmacology, New York: Springer.
Yatagai F, Saito T, Takahashi A, Fujie A, Nagaoka S, Sato M, Ohnishi T (2000) rpsL mutation induction after space flight on MIR. Mutation Research 453: 1-4
Zander J, Besier S, Faetke S, Saum SH, Müller V, Wichelhaus TA (2010) Antimicrobial activities of trimethoprim/sulfamethoxazole, 5-iodo-2'-deoxyuridine and rifampicin against Staphylococcus aureus. International Journal of Antimicrobial Agents 36: 562-565